未登录 分享 收藏
Enhancing outcomes in mCRPC: the impact of androgen receptor inhibitor sequencing before 177Lu-PSMA-617 therapy 增强mCRPC患者结局：在177Lu-PSMA-617治疗前行雄激素受体抑制剂序贯治疗的影响 Yazgan, Sati Coskun; Kayas, Kamil; Arslan, Cagatay; Kapar, Caner; Oztekin, Sura; Ceylan, Furkan; Bolek, Hatice; Elboga, Umut; Ates, Ozturk; Tural, Deniz; Kus, Tulay; Sendur, Mehmet Ali Nahit; Yekeduz, Emre; Kucuk, Nuriye Ozlem; Ozdemir, Elif Cingi; Urun, Yuksel 分享 收藏
分享 收藏
分享 收藏
The impact of smoking on nivolumab outcomes in renal cell carcinoma: real-world data from the Turkish Oncology Group Kidney Cancer Consortium 吸烟对纳武利尤单抗治疗肾细胞癌结局的影响：土耳其肿瘤学组肾癌联盟的真实世界数据 Camoz, Elif Sertesen; Bolek, Hatice; Kuzu, Omer Faruk; Sim, Saadet; Karakas, Hilal; Sekmek, Serhat; Guliyev, Murad; Akkus, Aysun Fatma; Isik, Selver; Tural, Deniz; Arslan, Cagatay; Goksu, Sema Sezgin; Sever, Ozlem Nuray; Karadurmus, Nuri; Karacin, Cengiz; Ozguroglu, Mustafa; Sendur, Mehmet Ali Nahit; Yekeduz, Emre; Urun, Yuksel 分享 收藏
分享 收藏
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium 舒尼替尼在转移性肾细胞癌中的应用：土耳其肿瘤学组肾癌协作组中不同风险组的临床结局 Bolek, Hatice; Kuzu, Omer Faruk; Sertesen Camoz, Elif; Sim, Saadet; Sekmek, Serhat; Karakas, Hilal; Isik, Selver; Guliyev, Murad; Akkus, Aysun Fatma; Tural, Deniz; Arslan, Cagatay; Goksu, Sema Sezin; Sever, Ozlem Nuray; Karadurmus, Nuri; Karacin, Cengiz; Sendur, Mehmet Ali Nahit; Yekeduez, Emre; Urun, Yuksel 分享 收藏
Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey 研究Ki-67表达与Oncotype DX复发评分之间的相关性和一致性：来自土耳其一项多中心研究的结果 Uras, C.; Tsoulos, N.; Giannoulakis, S.; Kapetsis, G.; Ergoren, M. Cerkez; Olgun, P.; Diker, O.; Karanlik, H.; Bilir, C.; Arslan, C.; Igci, A.; Karabulut, B.; Gorumlu, G.; Butun, O.; Gulum, N.; Kirca, O.; Ozdogan, M. 分享 收藏
分享 收藏
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma simlukafusp alfa (FAP-IL2v) 联合阿特珠单抗治疗复发和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的2期研究 Verlingue, Loic; Italiano, Antoine; Prenen, Hans; Alia, Eva Maria Guerra; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R.; Deva, Sanjeev; Taus, Alvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Rosello-Keranen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgraber, Volker; Keshelava, Nino; Dziadziuszkoz, Rafal 分享 收藏
分享 收藏
Outcomes of patients (pts) with unfavourable, nonsquamous cancer of unknown primary (CUP) progressing after induction chemotherapy (CTX) in the global, open-label, phase II CUPISCO study CUPISCO全球开放标签II期研究中，接受诱导化疗（CTX）后进展的预后不良、非鳞癌来源不明肿瘤（CUP）患者的结局 Bochtler, T.; Kraemer, A.; Pauli, C.; Duran-Pacheco, G.; Arslan, C.; Bigot, F.; Chalabi, N.; Cook, N.; Italiano, A.; Losa, F.; Menezes, J.; Ma, N.; Ozguroglu, M.; Pazo Cid, R. A.; Ross, J. S.; Shiu, K-K.; Arni, P.; Moch, H.; Mileshkin, L. 分享 收藏
分享 收藏
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study Kraemer, Alwin; Bochtler, Tilmann; Pauli, Chantal; Shiu, Kai-Keen; Cook, Natalie; de Menezes, Juliana Janoski; Pazo-Cid, Roberto A.; Losa, Ferran; Robbrecht, Debbie G. J.; Tomasek, Jiri; Arslan, Cagatay; Ozguroglu, Mustafa; Stahl, Michael; Bigot, Frederic; Kim, Sun Young; Naito, Yoichi; Italiano, Antoine; Chalabi, Nassera; Duran-Pacheco, Gonzalo; Michaud, Chantal; Scarato, Jeremy; Thomas, Marlene; Ross, Jeffrey S.; Moch, Holger; Mileshkin, Linda 分享 收藏
Efficacy of olaparib (ola) plus abiraterone (abi) vs placebo (pbo) plus abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial Mehra, N.; Clarke, N. W.; Armstrong, A. J.; Oya, M.; Shore, N. D.; Procopio, G.; Guedes, J. D. C.; Arslan, C.; Parnis, F.; Brown, E.; Schlurmann, F.; Joung, J. Y.; Sugimoto, M.; Choi, Y. D.; Castellano, D.; Urun, Y.; Hosius, C.; Desai, C.; Degboe, A.; Saad, F. 分享 收藏
Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP) Mileshkin, L.; Bochtler, T.; Pauli, C.; Duran-Pacheco, G.; Arslan, C.; Bigot, F.; Chalabi, N.; Cook, N.; Italiano, A.; Losa, F.; Menezes, J.; Michaud, C.; Ozguroglu, M.; Cid, R. A. Pazo; Ross, J. S.; Shiu, K. K.; Stahl, M.; Thomas, M.; Moch, H.; Kraemer, A. 分享 收藏
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors Yucel, Kadriye Bir; Yekeduz, Emre; Karakaya, Serdar; Tural, Deniz; Erturk, Ismail; Erol, Cihan; Ercelep, Ozlem; Oztas, Nihan Senturk; Arslan, Cagatay; Ucar, Gokhan; Kucukarda, Ahmet; Sever, Ozlem Nuray; Kilickap, Saadettin; Can, Orcun; Yazgan, Sati Coskun; Oksuzoglu, Berna; Karadurmus, Nuri; Sendur, Mehmet Ali; Urun, Yuksel 分享 收藏
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database Yekeduz, Emre; Erturk, Ismail; Tural, Deniz; Karadurmus, Nuri; Karakaya, Serdar; Hizal, Mutlu; Arikan, Rukiye; Arslan, Cagatay; Taban, Hakan; Kucukarda, Ahmet; oztas, Nihan Senturk; Sever, ozlem Nuray; Ucar, Gokhan; Can, Orcun; Nahit Sendur, Mehmet Ali; Demirci, Umut; Kilickap, Saadettin; Cicin, Irfan; Oksuzoglu, Berna; ozguroglu, Mustafa; Urun, Yuksel 分享 收藏
Multicenter real life experience of biological agents in patients with metastatic colorectal cancer Demirci, U.; Erturk, I.; Arslan, C.; Bilici, A.; Cevik, D.; Cicin, I.; Dane, F.; Dolek, B.; Kaplan, M.; Karadurmus, N.; Kose, F.; Sendur, M.; Urun, Y.; Kilickap, S. 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
Future Oncology.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
OAAI
OAAI